Business

Evotec SE: Results of the Annual General Meeting 2025

All agenda items adopted Under the topic "Pioneering Drug Discovery" CEO Dr Christian Wojczewski presented Evotec's current situation and strategic outlook 46.45% of the registered share capital represented HAMBURG, Germany - June 3, 2025 (NEWM...

Evotec SeJune 3, 20252
Evotec SE: Results of the Annual General Meeting 2025

About this update from Evotec Se

View stock analysis, news, and events for Evotec Se

Annual General MeetingEvotecFrankfurt Stock Exchangethe CompanySupervisory Boardshareholders

More from Evotec Se

All Evotec Se news →